<p>Healthcare analysts Tulip Lim and Ji Liu drop in on the S&P Pharma Guy, Arthur Wong, to talk how HHS's proposal to ban rebating from the Medicare market. What's the impact on the ratings of the pharma supply chain players?</p>

Healthcare analysts Tulip Lim and Ji Liu drop in on the S&P Pharma Guy, Arthur Wong, to talk how HHS's proposal to ban rebating from the Medicare market. What's the impact on the ratings of the pharma supply chain players?

<p>Healthcare analysts Tulip Lim and Ji Liu drop in on the S&amp;P Pharma Guy, Arthur Wong, to talk how HHS's proposal to ban rebating from the Medicare market. What's the impact on the ratings of the pharma supply chain players?</p>

Episode 30: Rebates And Pharma Supply Chain

Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.

Business

News

Business News

Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&amp;P Pharma Dose podcast from S&amp;P Global Ratings discusses all things pharma from a credit perspective.

Share Episode 30: Rebates And Pharma Supply Chain

Sign up to save your podcasts

Episode 30: Rebates And Pharma Supply Chain

Episode 30: Rebates And Pharma Supply Chain